BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2725943)

  • 21. [Malignant mesothelioma of the pleura--diagnostic difficulties].
    Drozdowska A; Damps-Konstańska I; Kobierska-Gulida G; Madrzak J; Kuziemski K; Pieńkowska J; Ucińska R; Słomiński JM
    Pol Merkur Lekarski; 2004 Oct; 17(100):380-1. PubMed ID: 15690708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is malignant mesothelioma of the pleura only an occupational disease?].
    Foresti V; Villa A; Scolari N; Parisio E
    Minerva Med; 1989 Feb; 80(2):145-8. PubMed ID: 2927705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Peritoneal mesothelioma].
    Pitrelli N; Di Bartolomeo N; Grossi S; Innocenti P; Pizzicannella G
    G Chir; 1995 Mar; 16(3):100-2. PubMed ID: 7547118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
    Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A
    Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and staging of malignant pleural mesothelioma].
    Sohrab S; Konietzko N
    Pneumologie; 2002 Jun; 56(6):382-7. PubMed ID: 12063622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Morphology, diagnosis and differential diagnosis of mesothelioma].
    Wu RL; Peng JQ
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):123-5. PubMed ID: 3208650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
    Yuasa H; Tomoyasu M
    Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Benign fibrous mesothelioma of the pleura].
    Oliaro A; Filosso PL; Casadio C; Ruffini E; Cianci R; Porrello C; Molinatti M; Cavallo A; Pischedda F; Rizzo M
    Minerva Chir; 1994 Dec; 49(12):1311-6. PubMed ID: 7746454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study.
    Mårtensson G; Hagmar B; Zettergren L
    Eur J Respir Dis; 1984 Apr; 65(3):169-78. PubMed ID: 6723826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesothelioma--short latent period after industrial asbestos exposure and prolonged survival.
    Abratt RP; Willcox PA; Casserley RD; Uys CJ
    Eur J Surg Oncol; 1985 Sep; 11(3):279-82. PubMed ID: 4029409
    [No Abstract]   [Full Text] [Related]  

  • 31. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.
    Kao SC; Pavlakis N; Harvie R; Vardy JL; Boyer MJ; van Zandwijk N; Clarke SJ
    Clin Cancer Res; 2010 Dec; 16(23):5805-13. PubMed ID: 20956618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mesothelioma of the pleura in the Province of Trieste].
    Bianchi C; Bianchi T; Tommasi M
    Med Lav; 2007; 98(5):374-80. PubMed ID: 17907531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunohistochemistry of mesotheliomas. Technique and current diagnostic contribution of immunohistochemical markers. General review].
    Galateau-Salle F
    Arch Anat Cytol Pathol; 1993; 41(5-6):212-22. PubMed ID: 8135582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Malignant mesothelioma of the pleura].
    Erika V; Zoltán S; Miklós Z; Judit A; Akos L; Kálmán K
    Orv Hetil; 1996 Feb; 137(5):233-8. PubMed ID: 8882441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estimates of pleural mesothelioma incidence in the Lazio region (Italy), 1997-2000].
    Palange S; Ascoli V; Carnovale-Scalzo C; Forastiere F; D'Ippoliti D; Presti EL; Di Domenicantonio R; Pasetto R; Perucci CA
    Med Lav; 2004; 95(1):45-54. PubMed ID: 15112747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal mesothelioma in a case of inguinal hernia. A review of the literature.
    Torretta A; La Torre V; Sorcini A; Panarese A; Tonini E; Zeri KP; Mascagni D; Arcieri S; Giacomelli L; Filippini A
    Ann Ital Chir; 2003; 74(5):583-7. PubMed ID: 15139717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells.
    Tsukiji H; Takeshima Y; Amatya VJ; Kushitani K; Inai K
    Histopathology; 2010 Jun; 56(7):969-74. PubMed ID: 20636799
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cystic mesothelioma of the peritoneum: a clinical case report].
    Palumbo P; Veronesi S; Girolami M; Guglielmi R; Crispino M; Bellucci A; Vietri F
    G Chir; 1992; 13(1-2):37-9. PubMed ID: 1581164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant mesothelioma presenting in the pleura and peritoneum.
    Wouters EF; Havenith MG; Vermeulen A; Greve LH
    Neth J Med; 1984; 27(6):213-7. PubMed ID: 6462309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.